Delphine Diagnostics’ Founder & CEO, Andy Bala, participated in the Medlantic Conference at the Princeton Innovation Center BioLabs, New Jersey.
The conference brought together healthcare leaders, investors, physicians, and innovators to discuss AI, healthcare innovation, funding pathways, and the future of clinical decision-making. The discussions aligned closely with Delphine’s mission to advance earlier infection diagnosis and improve patient outcomes.
